Rank:                   Amit Mehta, MD
Assistant Professor

Campus Address: NP 2540

Mailing Address: 
1720 2nd Avenue South, NP2540
Birmingham, AL 35294-3300

Phone:  (205) 996-8400

For an appointment, call (205) 934-9999 or toll free 1 (800) UAB-8816.

Medical School:
Medical College Baroda - India

Internal Medicine Residency:
Providence Hospital - George Washington University, Washington, D.C.

Hematology/Oncology, University of Alabama at Birmingham


Board certified in Internal Medicine
Board certified in Hematology
Board certified in Medical Oncology

American Society of Clinical Oncology
       Merit Award 2014 (Genitourinary)

American Society of Clinical Oncology (ASCO)
    Conquer Cancer Foundation - Your Investigator Award 2014

"I am currently assistant professor and associate scientist at the University of Alabama at Birmingham Comprehensive Cancer Center (UABCCC). I am board certified in Internal Medicine, Hematology and Oncology. My focus of interest is LYMPHOMA (Hodgkin lymphoma, Non Hodgkin lymphoma-T cell and B cell lymphomas). I specialize in treatments all types of lymphoma in my clinic. I am also involved in lymphoma related research, which includes genomic and proteomic (gene and protein related) studies in various kinds of lymphomas. As a clinical investigator I am also part of many clinical trials as principal investigator or sub investigator particularly in lymphomas. Many new promising targeted and immunologic treatments for lymphomas are being developed at UABCCC, which patients of lymphoma can benefit.

My passion is to develop targeted and immunologic therapies in lymphomas with less toxicities and more effectiveness.

My Research:


My research area involves:

-Development of newer agents and combination of newer biologic agents in various kinds of lymphomas. I am principal investigator and sub investigator in many Phase I, II or III clinical trials. My passion is to develop biologic therapies with less toxicities and more effectiveness.

-Survivorship research which involves well being of all lymphoma patients who have been exposed to chemotherapy, radiation therapy or had bone marrow transplant in past.

-Development of blood test to diagnose and monitor lymphoma during and after treatment. This highly sensitive blood test identifies tumor related genes to monitor lymphoma. This test is still in developmental phase but may eliminate need for biopsies in future.


-Lymphomas are biologically diverse tumors. Learning about their genetic make up and protein expression help us understand about their biology and develop new targeted and biological treatments. I collaborate with basic scientists and analyze lymphoma biopsies to understand biologic diversity and develop newer therapies.

UAB Lymphoma program:

UABCCC lymphoma program is comprehensive program involving specialists (medical oncology, surgical oncology, radiation oncology, Bone marrow transplant, survivorship and integrative medicine) and great nurses.

Apart from lymphomas, I also see patients with blood cancers (malignant hematology) and blood related disorders (benign hematology).

You can call my clinic (205-934-5077) or office (205-996-8400) for initial consultation, second opinions or clinical trials.

Special Interests:

  • Lymphoma
  • Diffuse large B-cell
  • Follicular lymphoma
  • Hodgkin Lymphoma
  • Mantle Cell Lymphoma
  • T-Cell Lymphoma
  • Other B-Cell Lymphomas
  • Agressive Lymphomas
  • Any kind of skin lymphomas (Cutaneous T cell/B cell lymphomas)
  • Targeted Therapy
  • Clinical Trials
  • Disparity Research

Access Dr. Mehta's profile on Linkedin and Doximity.

Publications: See a listing of publications on PubMed, a service of the National Library of Medicine.